Many contributing factors exist for why Gen X (born between 1965 and 1980) leads the way in semaglutide usage, including: Higher disposable income: Gen X people tend to be in the peak earning years of their careers, allowing for the financial resources needed to purchase semaglutide, which can be prohibitively expensive Greater health concerns: Individuals begin to experience more pronounced health concerns around their 40s to 60s, including those related to weight management such as obesity and diabetes, providing an added impetus to seek an effective weight loss solution Differences in semaglutide usage across different age groups and demographics As of 2024, the breakdown of semaglutide patients in the U.S
The outermost layer, the stratum corneum, restricts the penetration of large molecules
Key to success with semaglutide is maintaining a balanced, nutrient-rich diet
Having a higher weight or other underlying conditions such as diabetes can lead to negative effects on muscles, tendons, and joints
These added costs come from treating increased rates of heart and kidney disease, high cholesterol, diabetes and other negative health outcomes among nearly 40% of Tennesseans who qualify as obese, or having a body mass index above 30
The European Medicines Agency (EMA) and NICE have not issued guidance recommending GLP-1 receptor agonists for autoimmune disease management, reflecting the current lack of robust, high-quality evidence from randomised controlled trials
